We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

The ASPEN Study

Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis – The ASPEN Study

woman coughing
Age: 14-85 years old
Sex at Birth: All
Type: Interventional Drug Study
Condition: Non-cystic fibrosis bronchiectasis (NCFBE)
Healthy Participants: No
Location: UH Cleveland Medical Center

Learn More About This Research Study

For more information, please email or call (216-286-9678) the study coordinator Aja Patterson, or complete the online form below.

Study Purpose

The purpose of this study is to evaluate the efficacy, safety, and tolerability of an experimental treatment, brensocatib, for NCFBE.

Who Can Participate

Participants between 14-85 years of age diagnosed with NCFBE may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot